Suite 01 · Workflows 01 & 08

Eliminate unstable folds and host liabilities before ordering DNA.

Static structure confidence scores miss unclosed active sites, unpaired ER cysteines, glycan active-site occlusion, and thermal breathing. We audit candidate batches in explicit solvent and engineer clean, refolded variants ready for synthesis.

Configure Workflow 01 or 08 → Workflow 01: Stability Screen Workflow 08: Liability Scrubbing
300–330 K
Explicit-Solvent MD
OpenMM trajectories calibrated against matched-topology controls
Host QC
Secretion & PTM Audit
Flags unpaired cysteines, active-site glycans & protease clips pre-synthesis
20–50
Candidates per Screen
Monomers, oligomers, metalloproteins & giant repeats (2,500 aa single-pass; 5,000+ aa stitched / cloud GPU)
10–25
Scrubbed Variants
Active-site-locked sequences independently refolded and MD-verified
Workflow 01 · Pre-Synthesis Stability Screen

Explicit-solvent triage & host compatibility check on 20–50 designs.

Built for teams narrowing AlphaFold 3, Boltz-2, OpenFold 3, RFdiffusion, ProteinMPNN, or metagenomic candidate pools down to a high-confidence synthesis plate. Rather than applying arbitrary fixed RMSD cutoffs, every run includes matched intact and destabilized control structures (1.13 Å vs. 2.49 Å mean 330 K drift—a 1.36 Å separation in our pre-registered benchmark) alongside active-site distance checks to separate stable folds from designs that come apart under heat.

$5,000 – $10,000
3–10 business days · 50% start / 50% Net-15

01 · You Provide

  • 20–50 amino-acid FASTAs or predicted 3D structures (PDB/mmCIF)—up to 2,500 residues in a single local pass, 5,000+ residues via phase-matched window stitching (tested to 8,600 aa), or larger complexes on dedicated cloud GPUs.
  • Intended expression host (e.g., E. coli cytosol, Pichia / Aspergillus / CHO secretion, or cell-free).
  • Optional catalytic triad, cofactor, ligand pocket, or oligomeric interface residues to monitor.
  • 1–2 known active benchmark sequences (or we select public structural controls).

02 · Computational Protocol

  • Boundary & leader audit: checks miscalled start codons, signal peptides, pro-sequences, and truncated repeat or domain ends.
  • Host disulfide & glycosylation audit: 3D separation of structural disulfides (≤7.5 Å Cα–Cα) from unpaired ER-retaining cysteines, plus active-site N-glycan occlusion.
  • Explicit-water OpenMM MD: solvated, charge-neutralized 300 K and 330 K trajectories tracking local flexibility, pocket persistence, and oligomeric interface stability.

03 · Deliverable Package

  • Per-candidate biophysical scorecard (CSV/JSON + executive PDF summary) separating pass, warning, and structural failure modes.
  • 300 K & 330 K trajectory metrics, active-site distance distributions, and matched-control comparison bands.
  • Equilibrated 3D coordinate snapshots (PDB/mmCIF) and complete OpenMM force-field & parameter logs.
Package Tier Cohort & Simulation Depth Turnaround Fixed Fee
Triage Screen 20–50 candidates; full sequence/host liability audit + 0.5 ns 300 K / 330 K explicit-water relaxation screen 3–5 business days $5,000 – $7,500 Select tier →
Standard Screen 20–50 candidate audit + 10 ns explicit-water MD at 300 K & 330 K across top 10–15 designs + controls 5–7 business days $7,500 – $9,000 Select tier →
Extended Triplicate Full cohort triage + triplicate 50 ns+ independent trajectories on 3–5 lead candidates 7–10 business days $8,500 – $10,000 Select tier →
Workflow 08 · Constraint-Guided Optimization & Liability Scrubbing

Scrub ER cysteines, glycan traps, and PTM liabilities without breaking the fold.

When a promising enzyme or binder fails eukaryotic secretion or formulation stability due to exposed unpaired cysteines, N-X-S/T glycosylation sequons near the active site, Met/Trp oxidation hotspots, Asn-Gly deamidation, or host protease sites, naive point mutagenesis often collapses packing. We lock catalytic and interface coordinates while optimizing the surrounding sequence and verifying every variant by independent 3D refolding and explicit-water MD.

$8,000 – $15,000
5–8 business days · 50% start / 50% Net-15

01 · You Provide

  • 1–3 parent protein sequences or 3D models (monomer or symmetric homo-oligomer).
  • Target expression pathway (e.g., Pichia Kex2 secretion, Aspergillus, CHO, or cytosolic bacterial expression) and formulation pH/temperature.
  • Immutable residue list (catalytic triad, metal cage, epitope, or binding surface).

02 · Computational Protocol

  • Disulfide-safe cysteine cleanup: preserves paired structural disulfides, lipoboxes, and catalytic cysteines while substituting exposed unpaired cysteines that stall secretion.
  • Active-site-locked sequence redesign: simultaneously removes N-glycan traps, dibasic protease clips, deamidation/oxidation motifs, and aggregation-prone hydrophobic patches.
  • Independent 3D refolding & water MD: every proposed variant is refolded from scratch without templates and checked in 300 K / 330 K explicit water.

03 · Deliverable Package

  • 10–25 diversity-spaced, active-site-locked variant sequences with per-mutation biophysical rationale tables.
  • Refolded 3D PDB models + explicit-water backbone and active-site stability comparisons against the wild-type parent.
  • Related reading: Unpaired ER cysteines vs. structural disulfides →
Package Tier Optimization Scope Turnaround Fixed Fee
Monomer Scaffold Optimization 1 parent monomer; liability scrubbing + 10–25 independently refolded and MD-verified variants 5–7 business days $8,000 – $11,500 Select tier →
Homo-Oligomer or Multi-Parent Symmetric homo-oligomer interface-locked optimization or 2–3 related parent scaffolds 6–8 business days $11,500 – $15,000 Select tier →